Abstract
The ability of PAF-acether (platelet activating factor, 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) to induce neutrophil migration was tested in the peritoneal cavities of rats and guinea-pigs and in rat skin air pouches. PAF-acether, at doses of 2 and 5 μg per animal, did not promote significant neutrophil migration. The ability of PAF-acether antagonists to inhibit carrageenin induced neutrophil migration in rat abdominal cavities was also investigated. Carrageenin is a substance described to cause the release of endogenous PAF-acether. Neutrophil migration was not affected by PAF-antagonists. These observations challenge the possible role of PAF-acether as a neutrophil chemotactic factorin vivo.
Similar content being viewed by others
References
P. Braquet, L. Touqui, T. Y. Shen and B. B. Vargaftig,Perspectives in Platelet-activating factor research. Pharm. Rev.39, 97–145 (1987).
R. S. B. Cordeiro, M. A. Martim, P. M. R. e Silva, H. C. Castro Faria Neto, J. R. C. Castanheira and B. B. Vargaftig,Desensitization to PAF-induced rat paw oedema by repeated intraplantar injections. Life Sci.39, 1871–1878 (1986).
B. B. Vargaftig and S. H. Ferreira,Blockade of the inflammatory effects of platelet activating factor by cyclo-oxygenase inhibitors. Braz. J. Med. Biol. Res.14, 187–189 (1981).
J. O. Shaw, R. N. Pinckard, K. S. Ferrigni, L. M. Mcmanus and D. J. Hanahan,Activation of human neutrophils with 1.0 hexadecyl/octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine (platelet activating factor). J. Immunol.127, 1250–1255 (1981).
A. J. Wardlaw, M. R. C. P. Wardlaw and A. B. Kay,PAF-acether is a potent chemotactic factor for human eosinophils. J. of Allergy and Clinical Immunol77 (supl), 236 (1986).
B. M. Czarnetzki and J. Benveniste,Effect of synthetic PAF-acether on human neutrophil function. Les colloques de l'Inserm Pharmacology of inflammation and Allergy. (Eds. F. Russo Marie, B. B. Vergaftig and J. Benveniste). INSERM100, 105–109 (1981).
D. M. Humphrey, R. N. Pinckard, L. M. Mcmanus and D. J. Hanahan,Intradermal neutrophil infiltrates induced by 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholyne (AGEPC). Fed. Proceedings40, 1003 (1981).
D. M. Humphrey, D. J. Hanahan and R. N. Pinckard,Induction of leukocytic infiltrates in rabbit skin by acetyl-glyceryl-ether-phosphorylcholine. Lab. Invest.47, 227–234 (1982).
I. G. Colditz and H. Z. Movat,Desensitization of acute inflammatory lesions to chemotaxins and endotoxin. J. Immunol.133, 2163–2168 (1984).
I. G. Colditz and H. Z. Movat,Kinetics of neutrophil accumulation in acute inflammatory lesions induced by chemotaxins and chemotaxinigens. J. Immunol.133, 2169–2173 (1984).
P. M. R. Silva, R. S. B. Cordeiro, M. A. Martins, M. G. M. O. Henriques and B. B. Vargaftig,Platelet involvement in rat paw edema induced by 2-methoxy-PAF. Inflammation10, 393–401 (1986).
M. Di Rosa, J. P. Giroud and D. A. Willoughby,Studies of the mediators of the acute inflammatory response induced in rats in different sites carragenan and turpentine. J. Path.104, 15–29 (1971).
C. V. Wedmore and T. J. Williams,Control of vascular permeability by polymorphonuclear leucocytes in inflammation. Nature289, 646–650 (1981).
J. C. W. Edwards, A. D. Sedwick and D. A. Willoughby,The formation of a structure with the features of synovial lining by subcutaneous injection of air. An “in vivo” tissue culture system. J. Path.134, 147–153 (1981).
G. E. P. Souza and S. H. Ferreira,Blockade by antimacrophage serum of the migration of PMN neutrophils into the inflamed peritoneal cavity. Agents and Actions17, 97–103 (1985).
B. B. Lorenzetti, G. E. P. Souza, F. Q. Cunha and S. H. Ferreira,Anti-inflammatory effects of BN-52021. Proc. of 2nd Symposium “There is a Case for PAF-Acether Antagonists”. Paris, 1988.
A. W. Ford-Hutchinson, G. Brunet, P. Savard and S. Charleson,Leukotriene B4, polymorphonuclear leukocytes and inflammatory exudates in the rat. Prostaglandins28, 13–27 (1984).
M. J. H. Smith, A. W. Ford-Hutchinson and M. A. Bray,Leukotriene B: a potential mediator of inflammation. J. Pharm. Pharmacol.32, 517–518 (1980).
F. Q. Cunha and S. H. Ferreira,The release of a neutrophil chemotactic factor from peritoneal macrophages by endotoxin: inhibition by glucocorticoids. Eur. J. Pharmacol.129, 65–76 (1986).
P. C. Wilkinson,Cellular accumulation and inflammation. InTextbook of Immunopharmacology (Ed. M. M. Dale and J. C. Foreman) pp. 217–232. Blackwell Scientific Publications, Oxford 1984.
L. Parente and R. J. Flower,The generation of lyso-PAF in experimental inflammation. InInflammatory Mediators (Ed. G. A. Higgs and T. J. Williams), pp. 65–71. Macmillan Press, London 1985.
R. S. B. Cordeiro, P. M. R. Silva, M. A. Martins and B. B. Vargaftig,Salicylates inhibit PAF-acether-induced rat paw oedema when cyclooxigenase inhibitors are ineffective. Prostaglandins32, 719–727 (1986).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cunha, F.Q., Heluy-Neto, N.E., Klein, A. et al. Failure of PAF-acether to inducein vivo neutrophil migration. Agents and Actions 25, 191–194 (1988). https://doi.org/10.1007/BF01969111
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01969111